Autori: Dziadziuszko R
| Naslov | Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) (Meeting Abstract) |
| Autori | Kao SCH Reck M Liu SV Dziadziuszko R Hochmair MJ Huemer F Gilberto de Castro J Bernabe Caro R Kim SH Kowalski DM Andric Zoran G Oancea M Kaul M Li H Danner B Lee MC Nabet BY Sugawara S |
| Info | ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1638-S1638 |
| Projekat | F. Hoffmann-La Roche, Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C (Meeting Abstract) |
| Autori | Dziadziuszko R ... Andric Zoran G ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S950-S951 |
| Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
